We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
69 hedge funds and large institutions have $93.1M invested in State Street SPDR S&P Pharmaceuticals ETF in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 24 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
5.44% less ownership
Funds ownership: 47.37% → 41.93% (-5.4%)
12% less funds holding
Funds holding: 78 → 69 (-9)
13% less capital invested
Capital invested by funds: $107M → $93.1M (-$13.6M)
21% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 24
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
44% less call options, than puts
Call options by funds: $420K | Put options by funds: $756K
Holders
69
Holders Change
-9
Holders Change %
-11.54%
% of All Funds
1.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
19
Reduced
24
Closed
17
Calls
$420K
Puts
$756K
Net Calls
-$336K
Net Calls Change
+$84K
Top Buyers
| 1 |
FFM
Fullerton Fund Management
Singapore
|
+$2.14M |
| 2 |
JP Morgan Chase
New York
|
+$1.43M |
| 3 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$724K |
| 4 |
Jane Street
New York
|
+$537K |
| 5 |
Millennium Management
New York
|
+$318K |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$3.04M |
| 2 |
CF
Centaurus Financial
Anaheim,
California
|
-$2.63M |
| 3 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$1.93M |
| 4 |
FIM
FWL Investment Management
Dallas,
Texas
|
-$1.68M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.66M |
